Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Accuray Incorporated (ARAY) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Accuray Incorporated (ARAY) - free report >>
Image: Bigstock
Bear of the Day: Fresenius Medical (FMS)
The latest move higher in the market has boosted up all kinds of stocks. That means, even stocks with weak earnings trend have rebounded because they were simply so oversold. Be careful when you come in and buy the dip blindly. Sometimes, the stocks that are going up along with the rest of the market are not the quality names that you should be betting on.
One way to avoid stocks with weak earnings trends is passing on Zacks Rank #5 (Strong Sell) stocks. These stocks have seen earnings estimates drop over the last few weeks, which means that Wall Street could be turning bearish. Today’s Bear of the Day is one such stock. I’m talking about Zacks Rank #5 (Strong Sell) Fresenius Medical (FMS - Free Report) .
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Image Source: Zacks Investment Research
The reason for the unfavorable rank is that over the last 60 days, three analysts have cut estimates for the current year and next year. The negative moves have cut our Zacks Consensus Estimate for the current year from $1.67 to $1.46 while next year’s number is off from $1.86 to $1.56. That’s a 29% contraction this year and growth of just 6.7% next year.
The Medical -Instruments Peers industry ranks in the Bottom 48% of our Zacks Industry Rank. Investors looking for other names in this industry can check out Zacks Rank #1 (Strong Buy) Mesa Laboratories (MLAB - Free Report) and Zacks Rank #2 (Buy) Accuray (ARAY - Free Report) .